<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Problems</a></li><li><a href="#id7">Vital Signs</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">Assessments</a></li><li><a href="#id10">Plan Of Treatment</a></li><li><a href="#id11">Progress Notes</a></li><li><a href="#id12">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">PTH, INTACT AND CALCIUM (8837)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result1_attr1">PARATHYROID HORMONE, INTACT</td><td>37</td><td>16-77 pg/mL</td><td ID="result1_attr1_notes"><p/><p>Interpretive Guide    Intact PTH           Calcium</p><p>------------------    ----------           -------</p><p>Normal Parathyroid    Normal               Normal</p><p>Hypoparathyroidism    Low or Low Normal    Low</p><p>Hyperparathyroidism</p><p>   Primary            Normal or High       High</p><p>   Secondary          High                 Normal or Low</p><p>   Tertiary           High                 High</p><p>Non-Parathyroid</p><p>   Hypercalcemia      Low or Low Normal    High</p></td></tr><tr><td ID="result1_attr2">CALCIUM</td><td>8.8</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result2_attr1">GLUCOSE</td><td>96</td><td>65-99 mg/dL</td><td ID="result2_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result2_attr2">UREA NITROGEN (BUN)</td><td>15</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result2_attr3">CREATININE</td><td>0.97</td><td>0.60-1.00 mg/dL</td><td/></tr><tr><td ID="result2_attr4">EGFR</td><td>60</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result2_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result2_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result2_attr6">SODIUM</td><td>138</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result2_attr7">POTASSIUM</td><td>4.1</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result2_attr8">CHLORIDE</td><td>105</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result2_attr9">CARBON DIOXIDE</td><td>26</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result2_attr10">CALCIUM</td><td>8.8</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result2_attr11">PROTEIN, TOTAL</td><td>6.4</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result2_attr12">ALBUMIN</td><td>4.3</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result2_attr13">GLOBULIN</td><td>2.1</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result2_attr14">ALBUMIN/GLOBULIN RATIO</td><td>2.0</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result2_attr15">BILIRUBIN, TOTAL</td><td>0.7</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result2_attr16">ALKALINE PHOSPHATASE</td><td>75</td><td>37-153 U/L</td><td/></tr><tr><td ID="result2_attr17">AST</td><td>16</td><td>10-35 U/L</td><td/></tr><tr><td ID="result2_attr18">ALT</td><td>18</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED][REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result3_attr1">WHITE BLOOD CELL COUNT</td><td>5.7</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result3_attr2">RED BLOOD CELL COUNT</td><td>4.71</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result3_attr3">HEMOGLOBIN</td><td>14.5</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result3_attr4">HEMATOCRIT</td><td>45.3</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result3_attr5">MCV</td><td>96.2</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result3_attr6">MCH</td><td>30.8</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result3_attr7">MCHC</td><td>32.0</td><td>32.0-36.0 g/dL</td><td ID="result3_attr7_notes"><p>For adults, a slight decrease in the calculated MCHC</p><p>value (in the range of 30 to 32 g/dL) is most likely</p><p>not clinically significant; however, it should be</p><p>interpreted with caution in correlation with other</p><p>red cell parameters and the patient's clinical</p><p>condition.</p></td></tr><tr><td ID="result3_attr8">RDW</td><td>12.7</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result3_attr9">PLATELET COUNT</td><td>205</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result3_attr10">MPV</td><td>10.9</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result3_attr11">ABSOLUTE NEUTROPHILS</td><td>3295</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result3_attr12">ABSOLUTE LYMPHOCYTES</td><td>1921</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result3_attr13">ABSOLUTE MONOCYTES</td><td>325</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result3_attr14">ABSOLUTE EOSINOPHILS</td><td>131</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result3_attr15">ABSOLUTE BASOPHILS</td><td>29</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result3_attr16">NEUTROPHILS</td><td>57.8</td><td/><td/></tr><tr><td ID="result3_attr17">LYMPHOCYTES</td><td>33.7</td><td/><td/></tr><tr><td ID="result3_attr18">MONOCYTES</td><td>5.7</td><td/><td/></tr><tr><td ID="result3_attr19">EOSINOPHILS</td><td>2.3</td><td/><td/></tr><tr><td ID="result3_attr20">BASOPHILS</td><td>0.5</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result4_attr1">HEMOGLOBIN A1c</td><td>5.8</td><td>&lt;5.7 % of total Hgb</td><td ID="result4_attr1_notes"><p>For someone without known diabetes, a hemoglobin</p><p>A1c value between 5.7% and 6.4% is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p><p>For someone with known diabetes, a value &lt;7%</p><p>indicates that their diabetes is well controlled. A1c</p><p>targets should be individualized based on duration of</p><p>diabetes, age, comorbid conditions, and other</p><p>considerations.</p><p>This assay result is consistent with an increased risk</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p></td></tr><tr><td colspan="4"><span class="content_span">VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result5_attr1">VITAMIN B12</td><td>350</td><td>200-1100 pg/mL</td><td ID="result5_attr1_notes"><p/><p>Please Note: Although the reference range for vitamin</p><p>B12 is 200-1100 pg/mL, it has been reported that between</p><p>5 and 10% of patients with values between 200 and 400</p><p>pg/mL may experience neuropsychiatric and hematologic</p><p>abnormalities due to occult B12 deficiency; less than 1%</p><p>of patients with values above 400 pg/mL will have symptoms.</p></td></tr><tr><td ID="result5_attr2">FOLATE, SERUM</td><td>23.7</td><td/><td ID="result5_attr2_notes"><p>                           Reference Range</p><p>                           Low:           &lt;3.4</p><p>                           Borderline:    3.4-5.4</p><p>                           Normal:        &gt;5.4</p></td></tr><tr><td colspan="4"><span class="content_span">TSH W/REFLEX TO FT4 (36127)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result6_attr1">TSH W/REFLEX TO FT4</td><td>4.50</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result7_attr1">VITAMIN D,25-OH,TOTAL,IA</td><td>24</td><td>30-100 ng/mL</td><td ID="result7_attr1_notes"><p>Vitamin D Status         25-OH Vitamin D:</p><p>Deficiency:                    &lt;20 ng/mL</p><p>Insufficiency:             20 - 29 ng/mL</p><p>Optimal:                 &gt; or = 30 ng/mL</p><p>For 25-OH Vitamin D testing on patients on</p><p>D2-supplementation and patients for whom quantitation</p><p>of D2 and D3 fractions is required, the QuestAssureD(TM)</p><p>25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order</p><p>code 92888 (patients &gt;2yrs).</p><p>See Note 1</p><p>Note 1</p><p>For additional information, please refer to</p><p>http://education.QuestDiagnostics.com/faq/FAQ199</p><p>(This link is being provided for informational/</p><p>educational purposes only.)</p></td></tr><tr><td colspan="4"><span class="content_span">B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>Reviewed date:[REDACTED] 09:50:06 AM<br/>Interpretation:<br/>Performing Lab:EN, Quest Diagnostics-[REDACTED]-3226 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result8_attr1">B TYPE NATRIURETIC PEPTIDE (BNP)</td><td>42</td><td>&lt;100 pg/mL</td><td ID="result8_attr1_notes"><p/><p>BNP levels increase with age in the general</p><p>population with the highest values seen in</p><p>individuals greater than 75 years of age.</p><p>Reference: J. Am. Coll. Cardiol. 2002; 40:976-982.</p></td></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Reviewed date:[REDACTED] 10:34:01 AM<br/>Interpretation:<br/>Performing Lab:Z4M, Cleveland HeartLab Inc.-Cleveland HeartLab Inc.[REDACTED][REDACTED] [REDACTED] PhD,DABCC<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result9_attr1">CHOLESTEROL, TOTAL</td><td>TNP</td><td/><td ID="result9_attr1_notes"><p>locate for testing.</p><p>TEST NOT PERFORMED</p><p>The specimen was sent to a Quest</p><p>Diagnostics reference/esoteric</p><p>laboratory, but we are unable to</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>Establish Care</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Losartan Potassium 25 MG</td><td ID="instruction1">take 1/2 tablet daily Oral for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Metoprolol Succinate ER 25 MG</td><td ID="instruction2">take 1/2 tablet by mouth once daily Oral for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Atorvastatin Calcium 40 MG</td><td ID="instruction3">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Aspirin 81 81 MG</td><td ID="instruction4">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Former Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Control (Standard)</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>Former smoker</td><td/></tr><tr><td>How long has it been since you last smoked?</td><td>Greater than 10 years</td><td/></tr></tbody></table><span class="content_span">AUDIT-C (Standard)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Vitamin D deficiency (34713006)</td><td ID="Problem1">Vitamin D deficiency (E55.9)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hypertension (38341003)</td><td ID="Problem2">Hypertension (I10)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Cardiomyopathy (85898001)</td><td ID="Problem3">Myocardiopathy (HCC-CMS) (I42.9)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hypercholesterolemia (13644009)</td><td ID="Problem4">Hypercholesterolemia (E78.00)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>98.3 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>154 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>73 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Heart Rate</th><td>59 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Height</th><td>62 in</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Weight</th><td>172.8 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital7">BMI</th><td>31.6 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital8">Oximetry</th><td>94 %</td><td>[REDACTED]</td></tr><tr><th ID="vital9">Height-cm</th><td>157.48 cm</td><td>[REDACTED]</td></tr><tr><th ID="vital10">Weight-kg</th><td>78.38 kg</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>CAMG Yucaipa 104</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Pulmonary fibrosis J84.10 ; Secondary aldosteronism E26.1 ; Vitamin D deficiency E55.9 ; Hypercholesterolemia E78.00 ; Chronic combined systolic and diastolic congestive heart failure I50.42 ; Senile purpura (CMS/HCC) (HCC) D69.2 ; Aortic ectasia I77.819 ; Cardiomyopathy, unspecified I42.9 ; Alcohol dependence in remission F10.21 ; Aortic atherosclerosis (HCC) I70.0 ; Stage 3a chronic kidney disease (CMS/HCC) (HCC) N18.31 ; [REDACTED], unspecified J43.9 ; Hypertensive heart and chronic kidney disease with heart failure I13.0 and Peripheral vascular disease I73.9</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Pulmonary fibrosis (ICD-10 - J84.10)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:21 PM &gt; [REDACTED] CT ANGIOGRAPHY OF THE CHEST, ABDOMEN AND PELVIS. Scarring and fibrosis is seen in the lung bases. (Notes added from the To Do list)</td></tr><tr><td ID="ref2">[REDACTED]</td><td>Secondary aldosteronism (ICD-10 - E26.1)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:23 PM &gt; Secondary to CHF. (Notes added from the To Do list)</td></tr><tr><td ID="ref3">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Hypercholesterolemia (ICD-10 - E78.00)</td><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Chronic combined systolic and diastolic congestive heart failure (ICD-10 - I50.42)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:26 PM &gt; [REDACTED] Echo EF 60% (Notes added from the To Do list)</td></tr><tr><td ID="ref6">[REDACTED]</td><td>Senile purpura (CMS/HCC) (HCC) (ICD-10 - D69.2)</td><td/><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Aortic ectasia (ICD-10 - I77.819)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:32 PM &gt; [REDACTED] NP [REDACTED] (Notes added from the To Do list)</td></tr><tr><td ID="ref8">[REDACTED]</td><td>Cardiomyopathy, unspecified (ICD-10 - I42.9)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:34 PM &gt; Echo [REDACTED] -- EF 30%-LLUH admission [REDACTED] (Notes added from the To Do list)</td></tr><tr><td ID="ref9">[REDACTED]</td><td>Alcohol dependence in remission (ICD-10 - F10.21)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:38 PM &gt; Sober since [REDACTED]. (Notes added from the To Do list)</td></tr><tr><td ID="ref10">[REDACTED]</td><td>Aortic atherosclerosis (HCC) (ICD-10 - I70.0)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:42 PM &gt; [REDACTED], [REDACTED] CXR (Notes added from the To Do list)</td></tr><tr><td ID="ref11">[REDACTED]</td><td>Stage 3a chronic kidney disease (CMS/HCC) (HCC) (ICD-10 - N18.31)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:44 PM &gt; GFRS [REDACTED] 57 [REDACTED] 49 [REDACTED] 58 (Notes added from the To Do list)</td></tr><tr><td ID="ref12">[REDACTED]</td><td>Emphysema, unspecified (ICD-10 - J43.9)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:47 PM &gt; [REDACTED] PFT (Notes added from the To Do list)</td></tr><tr><td ID="ref13">[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure (ICD-10 - I13.0)</td><td/><td/><td>[REDACTED] S [REDACTED] 15:38:49 PM &gt; HYPERTENSION with CKD and heart failure. (Notes added from the To Do list)</td></tr><tr><td ID="ref14">[REDACTED]</td><td>Peripheral vascular disease (ICD-10 - I73.9)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 2 Weeks, Reason: annual physical</td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:00:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] F) <span class="bold">Acc No.</span> 11518 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>11518</td><td align="right"><span class="bold">Provider: </span>[REDACTED] [REDACTED], MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>78 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED][REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. Establish Care. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Follow-up</span>: <br/>       <br/>CC: copd<br/>doing well,<br/>reports SOB worsening, low energy,<br/>Reports using rescue inhaler at the usual frequency, 3 times a week,<br/>no cough, no phlegm production.<br/>no fever,<br/>PLAN<br/>Using combivent<br/>stable, O2 within acceptable range, no warning symptoms for exacerbation,<br/>Discussed disease process, difference between rescue inhalers use and maintenance inhaler, reviewed medication administration instructions, frequency and timing.<br/><br/>Vitamin d def<br/>takes daily supplements<br/>continue the same<br/>will monitor level.<br/><br/>CKD 3 a<br/><br/>Lab Results<br/>Component Value Date<br/>EGFRNONAFRAM 58 (L) [REDACTED]<br/>will continue to monitor,<br/>Avoid nephrotoxic meds.<br/><br/><br/>CHF<br/>occasional leg swelling,<br/>no orthopnea<br/>EF 65-70% in [REDACTED], she had grade 1 diastolic dysfunction.<br/>on ASA, Statin, losartan, lopressor,<br/>Continue taking the Lopressor once a day half a tablet, will have her take half a tablet twice a day.<br/>PLAN<br/>Stable<br/>Cont the same,<br/><br/>2ry hyperaldosteronism,<br/>2ry to chf<br/>Asymptomatic,<br/>Electrolytes stable.<br/>PLAN<br/>Continue to monitor,<br/>Adjust diuretics if needed<br/><br/>HTN:<br/>No chest pain, no dizziness, no headache.<br/>uncontrolled.<br/>on losartan 25 mg (1/2 tab), toprol 25 mg 1/2 tab<br/>PLAN<br/>will increase losartan to full tablet, <br/>RTC 2-3 weeks. <br/>HTN controlled on current regimen, will refill medication (s). Discussed low salt diet, exercise regimen. Patient was counseled on hypertensive retinopathy and was advised to have routine ophthalmology exams at least once a year.<br/><br/>Senile purpura,<br/>purpuric rash over UE. small bruises on UE as well.<br/>plan patient on anticoagulation. No treatment suggested at this time, will continue to monitor.<br/><br/>PVD<br/>Patient reports no symptoms of intermittent claudication,<br/>Incidental finding,<br/>On antiplatelets/anticoagulation.<br/>PLAN<br/>Asymptomatic<br/>Continue the same. Continue to monitor<br/><br/>Prediabetes<br/>Lab Results<br/>Component Value Date<br/>HEMOGLOBINA1 5.2 [REDACTED]<br/><br/>working on diet and exercise, will continue to monitor.<br/><br/>CC FU HLD<br/>Stable on current dose of statin, tolerating it well with no side effects of muscle pains or aches. Will continue the same.<br/><br/><br/><br/>Generalized arthritis,<br/>Hands, painful both hands,<br/>No swelling,<br/>Neck pain, lower back pain.<br/>No radiculopathy,<br/>Occasional numbness lower ext, no constant.<br/>PLAN<br/>Tylenol, and exercises,<br/>Avoid NSAIDs due to CKD 3<br/><br/>Physical Activity Counseled with patient.<br/>Functional Status is stable.<br/>Medications reviewed and documented.<br/>Denies Urinary Incontinence.<br/>Patient's chronic medical problems were addressed and reviewed on [REDACTED] visit.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Patient denies change in appetite,  fever,  weakness, fatigue, fever, headache, night sweats.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Patient denies chronic cough,  shortness of breath,  sputum production.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Patient denies chest pain,  chest pain with exertion,  irregular heartbeat.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Patient denies abdominal pain,  diarrhea,  rectal bleeding.   <br/>   <span class="Underline">Hematology</span>: <br/>      Patient denies easy bleeding,  easy bruising,  recent transfusion.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Patient denies abdominal pain / swelling,  blood in the urine,  frequent urination.   <br/>   <span class="Underline">Skin</span>: <br/>      Patient denies blistering of skin,  changing moles,  skin lesion(s).   <br/>   <span class="Underline">Neurologic</span>: <br/>      Patient denies dizziness,  gait abnormality,  headache.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Patient denies delusions,  depressed mood,  difficulty sleeping.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> gallbladder removal , partial mastectomy (right breast) , tubal ligation , tonsillectomy , cyst removal from left buttock . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father:  lung cancer, heart attack. Mother:  heart attack, STROKE. Sister: deceased, heart disease, Heart Issues, Lung disease. Son:  blood disorder, leukemia, Heart Issues,  diagnosed with Hypercholesteremia. 2 sister(s) . 5 son(s) . . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Control (Standard) <br/>         Tobacco use: <span class="italics">Former smoker</span><br/>         How long has it been since you last smoked? <span class="italics">Greater than 10 years</span><br/>   <span class="Underline">Drug/Alcohol:</span> <br/>       AUDIT-C (Standard) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">No</span><br/>         Points <span class="italics">0</span><br/>         Interpretation <span class="italics">Negative</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking Aspirin 81 81 MG Tablet Delayed Release 1 tablet Orally Once a day , Taking Atorvastatin Calcium 40 MG Tablet 1 tablet Oral Once a day , Taking Metoprolol Succinate ER 25 MG Tablet Extended Release 24 Hour take 1/2 tablet by mouth once daily Oral  , Taking Losartan Potassium 25 MG Tablet take 1/2 tablet daily Oral  , Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> BP: 154/73 mm Hg, HR: 59 /min, Temp: 98.3 F, Oxygen sat %: 94 %, Wt: 172.8 lbs, Wt-kg: 78.38 kg, Ht: 62 in, Ht-cm: 157.48 cm, BMI: 31.6 Index, Body Surface Area: 1.85.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, pleasant, well-nourished and in no acute distress. <br/>      Head: normocephalic, atraumatic. <br/>      Eyes: pupils equal, round. <br/>      Nose: nares patent, no lesions. <br/>      Lymph nodes: no cervical lymphadenopathy. <br/>      Skin: skin is warm and dry, with no rashes, good skin turgor and normal hair distribution<br/>        <br/>        Purpuric rash over upper extremity small bruises on upper extremity as well. . <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Chest: normal shape and expansion. <br/>      Neurologic: alert and oriented, cognitive exam grossly normal. <br/>      Psych: with good judgement and insight, alert and oriented x 3.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Pulmonary fibrosis - J84.10 (Primary)   2. Secondary aldosteronism - E26.1   3. Vitamin D deficiency - E55.9   4. Hypercholesterolemia - E78.00   5. Chronic combined systolic and diastolic congestive heart failure - I50.42   6. Senile purpura (CMS/HCC) (HCC) - D69.2   7. Aortic ectasia - I77.819   8. Cardiomyopathy, unspecified - I42.9   9. Alcohol dependence in remission - F10.21   10. Aortic atherosclerosis (HCC) - I70.0   11. Stage 3a chronic kidney disease (CMS/HCC) (HCC) - N18.31   12. Emphysema, unspecified - J43.9   13. Hypertensive heart and chronic kidney disease with heart failure - I13.0   14. Peripheral vascular disease - I73.9   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Pulmonary fibrosis</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:21 PM &gt; [REDACTED] CT ANGIOGRAPHY OF THE CHEST, ABDOMEN AND PELVIS. Scarring and fibrosis is seen in the lung bases. <br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Secondary aldosteronism</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:23 PM &gt; Secondary to CHF. (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Vitamin D deficiency</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span></td></tr><tr><td/></tr><tr><td><span class="bold">4. Hypercholesterolemia</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span></td></tr><tr><td/></tr><tr><td><span class="bold">5. Chronic combined systolic and diastolic congestive heart failure</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:26 PM &gt; <span class="content_span">[REDACTED] Echo EF 60%</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Senile purpura (CMS/HCC) (HCC)</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span></td></tr><tr><td/></tr><tr><td><span class="bold">7. Aortic ectasia</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:32 PM &gt; <span class="content_span">[REDACTED] NP [REDACTED]</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Cardiomyopathy, unspecified</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:34 PM &gt; <span class="content_span">Echo [REDACTED] -- EF 30%-LLUH admission [REDACTED]</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Alcohol dependence in remission</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:38 PM &gt; <span class="content_span">Sober since [REDACTED].</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Aortic atherosclerosis (HCC)</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:42 PM &gt; <span class="content_span">[REDACTED], [REDACTED] CXR</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Stage 3a chronic kidney disease (CMS/HCC) (HCC)</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,[REDACTED] (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:44 PM &gt; <content>GFRS [REDACTED] 57<br/></content><content>[REDACTED] 49<br/></content><span class="content_span">[REDACTED] 58</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Emphysema, unspecified</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:47 PM &gt; <span class="content_span">[REDACTED] PFT</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr><tr><td><span class="bold">13. Hypertensive heart and chronic kidney disease with heart failure</span> <br/>     <span class="Underline">LAB: PTH, INTACT AND CALCIUM (8837)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127)</span><br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>     <span class="Underline">LAB: B TYPE NATRIURETIC PEPTIDE (BNP) (37386)</span><br/>     <span class="Underline">LAB: LIPID PANEL W/ TRIGLYCERIDES/HDL-C (37848)</span><br/>Clinical Notes: [REDACTED] S [REDACTED] 15:38:49 PM &gt; <span class="content_span">HYPERTENSION with CKD and heart failure.</span><br/> (Notes added from the To Do list)  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 2 Weeks (Reason: annual physical)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , MD  on [REDACTED] 03:24 PM PDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED] [REDACTED], MD</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 05:29 PM PST</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id12" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="11">General Examination</td><td>General appearance:</td><td colspan="2">alert, pleasant, well-nourished and in no acute distress</td></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Eyes:</td><td colspan="2">pupils equal, round</td></tr><tr><td>Nose:</td><td colspan="2">nares patent, no lesions</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs</td></tr><tr><td>Chest:</td><td colspan="2">normal shape and expansion</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Neurologic:</td><td colspan="2">alert and oriented, cognitive exam grossly normal</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes, good skin turgor and normal hair distribution  Purpuric rash over upper extremity small bruises on upper extremity as well. </td></tr><tr><td>Lymph nodes:</td><td colspan="2">no cervical lymphadenopathy</td></tr><tr><td>Psych:</td><td colspan="2">with good judgement and insight, alert and oriented x 3</td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>